Presented at the Association for Molecular Pathology (AMP) 2020 conference, this 50-minute workshop highlights two scientists’ experiences using OGT’s next generation sequencing (NGS) panels in their haematology workflows, alleviating the burden of running multiple assays and delivering comprehensive results with a single NGS analysis.
The two scientists will share their experiences of how OGT’s NGS panels have streamlined their laboratory workflow and enabled detection of a variety of aberrations, including CNVs in CLL and FLT3-ITDs and KMT2A-PTDs in myeloid disorders.
SureSeq™: For Research Use Only; Not for Diagnostic Procedures.
